LGND - Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
IEX Last Trade
105.63
-0.230 -0.218%
Share volume: 113,893
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$105.86
-0.23
-0.22%
Summary score
40%
Profitability
22%
Dept financing
24%
Liquidity
75%
Performance
54%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.5%
Return on assets
1.35%
Return on sales
11.18%
Return on invested capital
2.2%
Total debt ratio
28.43%
Debt ratio change over timeo
15.15%
Current Ratio
10.39%
Quick Ratio
9.78%
Cash Position Ratio
6.5%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.02%
Return on assets
1.71%
Return on sales
-1.73%
Return on invested capital
4.55%
Total debt ratio
12.04%
Debt ratio change over timeo
4.49%
Current Ratio
15.1%
Quick Ratio
13.82%
Cash Position Ratio
11.79%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
10.68%
Return on assets
12.45%
Return on sales
9.65%
Return on invested capital
16.34%
Total debt ratio
11.75%
Debt ratio change over time
2.44%
Current Ratio
20.7%
Quick Ratio
19.51%
Cash Position Ratio
17.43%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-18.02%
Return on assets
-50.59%
Return on sales
-630.08%
Return on invested capital
-1.15%
Total debt ratio
1515.06%
Debt ratio change over time
15.15%
Current Ratio
196.86%
Quick Ratio
176.89%
Cash Position Ratio
146.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LGND | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 1.5% | 18.83% | 17.34% | 7.6% |
| Return on assets | 1.35% | 4.16% | 8.21% | 3.22% |
| Return on sales | 11.18% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 2.2% | 9.79% | -219.55% | 7.46% |
| Profitability | 19% | 80% | 73% | 54% |
| Total debt ratio | 28.43% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | 15.15% | -4.38% | -0.73% | -33.74% |
| Dept financing | 34% | 25% | 17% | 18% |
| Current Ratio | 15.1% | 1.12% | 0% | 1.16% |
| Quick Ratio | 13.82% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 11.79% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 6% | 6% | 8% |
| Short-term ratios | LGND | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 3.02% | 13.31% | 0% | 13.48% |
| Return on assets | 1.71% | 4.72% | 0% | 3.05% |
| Return on sales | -1.73% | 31.4% | 0% | 25.56% |
| Return on invested capital | 4.55% | 10.68% | 0% | 13.96% |
| Profitability | 23% | 94% | 0% | 87% |
| Total debt ratio | 12.04% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | 4.49% | -41.82% | 0% | 7.13% |
| Dept financing | 19% | 25% | 0% | 43% |
| Current Ratio | 15.1% | 1.12% | 0% | 1.16% |
| Quick Ratio | 13.82% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 11.79% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 4% | 0% | 5% |